Better Communication between Reps and HCPs Using Big Data and Machine Learning
Have you ever hoped there was a better way to gain insights into the physicians your reps are calling on? Even no-see docs? A promising new technology offers this very solution to a nagging problem.
IQcentRx, LLC, recently announced the introduction of Call-IQ, a sales force alert system that informs and streamlines conversations between pharmaceutical reps and the doctors they call on.
Call-IQ draws on a continually-refreshed body of evidence about doctors’ searches, interactions and educational choices to produce immediate insights into their preferences, knowledge and prescribing habits.
This finally cracks the code of why doctors do what they do, and offers the field force specific wisdom that will satisfy the physician’s needs and make the reps’ calls more useful and productive.
With limited (or no) access, increased competition, a plethora of platforms, and a mountain of data to sort through, getting cozy with what HCPs are thinking – and what will instill trust and provoke action – is what every healthcare company is looking for. The advancement offered by this new approach is that its data sets are more behavioral, and not just Rx-specific.
It’s one thing to know that an HCP wrote a new script. It’s quite another to know why.
Call-IQ cuts way down on wasted calls, and even helps with ‘no-see’ docs who resist meetings with reps, but are open to pertinent breaking information. Call-IQ can be sent via email/text message, downloaded to an app on the rep’s phone and even integrated within their personalized CRM system. The service provides information down to the individual doctor level.
Who should be most interested in deploying this solution?
• Brand Directors, Pharma
• National Sales Directors, Pharma
IQcentRx believes that its products, using very high technology on the back of a robust database, and using machine learning capabilities, will increase market intelligence and lead to faster, better-informed sales cycles and marketing activities. If they are right, this could be a major inflection point in communications between reps and HCPs.
More info at http://bit.ly/IQcentRx